Skip to main content

Clinical Trial Results

Search

Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Benefits Of Sodium Glucose Co-transporter-1/2 Inhibition With Sotagliflozin Across The Full Spectrum Of Ejection Fraction, Including Heart Failure With Preserved Ejection Fraction

Disclosures: TBD